Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0.000550660792951628
Stock impact report

UroGen Pharma Reports First Quarter 2021 Financial Results and Recent Corporate Developments

UroGen Pharma Ltd. - Ordinary Shares (URGN) 
Last urogen pharma ltd. - ordinary shares earnings: 3/2 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.urogen.com
Company Research Source: Business Wire
Jelmyto® net product revenue of $7.5 million for the first quarter of 2021New patient starts in March and April of 2021 increased 100% and 165%, respectively, compared to new patient starts in January 2021Phase 3 ATLAS trial enrollment ongoing with new sites activated in EuropeActive platform expansion in immuno-oncology with commencement of strategic collaborations with leading academic institutionsConference call and webcast to be held today at 8:30 AM ET PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat specialty cancers and urologic diseases, today announced financial results for the first quarter ended March 31, 2021 and provided an overview of the Company’s recent developments.“We are pleased with the progress we have made across our expanded pipeline and the momentum we’ve seen since we reported fourth quarter 2020 earnings in March. The number of patient enrol Show less Read more
Impact Snapshot
Event Time:
URGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for URGN alerts
Opt-in for
URGN alerts

from News Quantified
Opt-in for
URGN alerts

from News Quantified